Investing.com - BioPorto reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
BioPorto announced earnings per share of kr-0.05 on revenue of kr6.50M. Analysts polled by Investing.com anticipated EPS of kr-0.06 on revenue of kr6.35M.
BioPorto shares are down 16% from the beginning of the year and are trading at kr1.474 , down-from-52-week-high.They are under-performing the S&P CLX IPSA which is up 25.77% from the start of the year.
BioPorto follows other major Healthcare sector earnings this month
BioPorto's report follows an earnings missed by Novo Nordisk B on August 4, who reported EPS of kr5.86 on revenue of kr41.27B, compared to forecasts EPS of kr5.96 on revenue of kr41.57B.
Coloplast had missed expectations on August 17 with third quarter EPS of kr6.14 on revenue of kr5.85B, compared to forecast for EPS of kr6.17 on revenue of kr5.85B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar